RVL Pharmaceuticals plc Annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from 2017 to 2022
-
Taxonomy & unit
-
us-gaap: pure
-
Description
-
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
-
Summary
-
RVL Pharmaceuticals plc quarterly/annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from 2017 to 2022.
- RVL Pharmaceuticals plc Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending June 30, 2023 was 0 pure, a 85.5% decline year-over-year.
- RVL Pharmaceuticals plc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.21 pure, unchanged from 2021.
- RVL Pharmaceuticals plc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2021 was 0.21 pure, unchanged from 2020.
- RVL Pharmaceuticals plc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2020 was 0.21 pure, unchanged from 2019.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Annual (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Annual Growth (%)